Company intelligence / Profile preview
Azora Therapeutics
- Ownership
- Private
- Employees
- ~1
- Development stage
- Phase 1
Overview
Azora Therapeutics is a clinical-stage biopharmaceutical company spun out of Stanford University’s SPARK program. It develops novel small molecule therapies—specifically oral and topical aryl hydrocarbon receptor agonists—for serious autoimmune and inflammatory diseases. Its lead programs target hidradenitis suppurativa, ulcerative colitis, and psoriasis. The company has completed or nearly completed several Phase 1b studies as of early/mid–2023. It owns worldwide royalty-free rights to its technology.[1][4][6][8]
- Therapeutic areas
- GastroenterologyDermatology
- Modalities
- Small molecules (novel new chemical entities)Aryl hydrocarbon receptor (AhR) agonists[1][4][5][8]
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Azora Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Azora Therapeutics.